Literature DB >> 2961843

The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens.

J Y Bonnefoy1, O Guillot, H Spits, D Blanchard, K Ishizaka, J Banchereau.   

Abstract

Two hybridomas that produce the mAbs 135 and 449 B4 were obtained that inhibited the binding of IgE to the Fc epsilon RL/CD23 on the EBV-transformed B cell line RPMI 8866. mAb 135 was obtained from a mouse immunized with RPMI 8866 cells, whereas mAb 449B4 was obtained from a mouse immunized with a partially purified preparation of Fc epsilon RL/CD23 obtained as the eluate of an IgE immunoabsorbent loaded with a soluble extract of RPMI 8866 cells. These two mAbs bound to Fc epsilon RL/CD23- cell lines and precipitated two polypeptides with 36,000 Mr and 28,000 Mr, which were the HLA-DR alpha and beta chains, respectively. Immunoprecipitation with mAb 135 of NP-40 lysates from dithio-bis(succinimidyl propionate) (DSP) crosslinked 125I-labeled RPMI 8866 or normal B cells incubated with rIL-4 showed three polypeptides with 42,000, 36,000, and 28,000 Mr. The 42,000 Mr polypeptide is identical to the Fc epsilon RL/CD23 since it could be precipitated by the anti-Fc epsilon RL/CD23 mAb 25 after resolubilization from the SDS-PAGE gel. Immunoprecipitations of the crosslinked cell extracts carried out with the anti-Fc epsilon RL/CD23 mAb 25 yielded the same three polypeptides. Furthermore, when RPMI 8866 or rIL-4 preincubated normal B cells were solubilized with a digitonin buffer, which prevents the dissociation of noncovalently linked polypeptide complexes, mAb 135 and mAb 25 precipitated complexes composed of three molecules with 42,000, 36,000, and 28,000 Mr. The well-characterized anti-HLA-DR mAb L243 was unable to block the binding of either IgE or mAb 135 to RPMI 8866 cells, although it could immunoprecipitate the complex (HLA-DR-Fc epsilon RL/CD23) from crosslinked cell lysates. Since mAb 135 and L243 were able to both bind the RPMI 8866 cells, it demonstrates that they bind to different epitopes of the HLA-DR complex, the mAb 135 epitope of the HLA-DR molecule being close to the IgE binding site of the Fc epsilon RL/CD23. These data demonstrated that the Fc epsilon RL/CD23 and HLA-DR antigens are spatially associated on the B cell membrane.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2961843      PMCID: PMC2188804          DOI: 10.1084/jem.167.1.57

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors.

Authors:  J Yodoi; K Ishizaka
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

2.  Studies on the nature of the relationship between Ia antigens and Fc receptors on murine B lymphocytes.

Authors:  H B Dickler; M T Kubicek; R D Arbeit; S O Sharrow
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

Review 3.  Regulation of IgE synthesis.

Authors:  K Ishizaka
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 4.  Regulation of the IgE system: experimental and clinical aspects.

Authors:  D H Katz
Journal:  Allergy       Date:  1984-02       Impact factor: 13.146

Review 5.  Characterization and function of T cell Fc gamma receptor.

Authors:  W H Fridman; C Rabourdin-Combe; C Neauport-Sautes; R H Gisler
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

6.  Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes.

Authors:  M Fehlmann; J F Peyron; M Samson; E Van Obberghen; D Brandenburg; N Brossette
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  The receptor for IgE on blood platelets.

Authors:  M Joseph; A Capron; J C Ameisen; M Capron; H Vorng; V Pancré; J P Kusnierz; C Auriault
Journal:  Eur J Immunol       Date:  1986-03       Impact factor: 5.532

8.  Characterization and isolation of IgE class-specific suppressor factor (IgE-TsF) I. The presence of the binding site(s) for IgE and of the H-2 gene products in IgE-TsF.

Authors:  M Suemura; O Shiho; H Deguchi; Y Yamamura; I Böttcher; T Kishimoto
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

9.  Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells.

Authors:  A B Schreiber; J Schlessinger; M Edidin
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

10.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  24 in total

1.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 3.  Surface molecules involved in B lymphocyte function.

Authors:  P Möller; A Eichelmann; G Moldenhauer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins.

Authors:  S Matsushita; J F Marcelletti; L R Katz; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL)

Authors:  N R Ling; F K Stevenson; B Brown
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

6.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

Review 7.  Fc epsilon receptor II-positive macrophages and platelets: potent effector cells in allergy and defence against helminth parasites.

Authors:  J P Dessaint; A Capron
Journal:  Springer Semin Immunopathol       Date:  1990

8.  Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

Authors:  M Billaud; P Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; T Tursz; G M Lenoir
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution.

Authors:  R L Beavil; P Graber; N Aubonney; J Y Bonnefoy; H J Gould
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.

Authors:  A H Hajeer; N Snowden; P Wilson; S Drover; W E Ollier
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.